Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib and/or Nivolumab plus Chemotherapy in Advanced Sarcomas
NCT03277924Phase 2Completed
- Sponsor
- Spanish Group for Research on Sarcoma
- Start
- May 2017
- Primary completion
- Jun 2024
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
Phase 2, open-label trial of nivolumab in soft tissue sarcoma (STS) and bone sarcoma, sponsored by Spanish Group for Research on Sarcoma. Started May 2017; status: completed.
02
Drugs
03
Conditions
soft tissue sarcoma (STS)bone sarcoma
Beyond the preview
Go deeper on NCT03277924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03277924.